3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
161
Squamous Cell Carcinoma of Head and Neck
95
Head and Neck Neoplasms
95
Colonic Neoplasms
46
Rectal Neoplasms
39
Neoplasm Metastasis
35
Carcinoma, Non-Small-Cell Lung
29
Carcinoma, Squamous Cell
25
Pancreatic Neoplasms
18
Neoplasms
18
Esophageal Neoplasms
18
Lung Neoplasms
17
Stomach Neoplasms
13
Laryngeal Neoplasms
12
Recurrence
11
Oropharyngeal Neoplasms
11
Mouth Neoplasms
11
Esophageal Squamous Cell Carcinoma
11
Colorectal Cancer Metastatic
10
Tongue Neoplasms
9
Carcinoma
9
Breast Neoplasms
9
Nasopharyngeal Carcinoma
8
Hypopharyngeal Neoplasms
8
Adenocarcinoma Of Esophagus
8
Laryngeal Diseases
6
Salivary Gland Neoplasms
5
Neoplasms, Squamous Cell
5
Glioblastoma
5
Uterine Cervical Neoplasms
4
Interventions
pembrolizumab
3
lenvatinib
3
gallium 68 PSMA-11
2
apatinib
2
Protons
2
Magnetic Resonance Spectroscopy
2
Imatinib Mesylate
2
Epirubicin
2
Cisplatin
2
Carboplatin
2
Axitinib
2
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
2
tislelizumab
1
regorafenib
1
enfortumab vedotin
1
cabozantinib
1
avelumab
1
anlotinib
1
amivantamab
1
abemaciclib
1
Tretinoin
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Sunitinib
1
Standard of Care
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Radiation
1
Pemetrexed
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Adenoid Cystic
×
Cetuximab
×
Clear all
NCT01192087
2013-04-24
ACCEPT
Heidelberg University
Phase 1/2
Unknown
49 enrolled